BioSpace News Archive

The REVOCAN phase 1b/2 study, sponsored by Gustave Roussy, will evaluate the effect of AsiDNA™ on the acquired resistance to PARP inhibitor niraparib in 2nd line maintenance treatment of relapsed ovarian cancer

Lincoln Educational Services Corporation (NASDAQ: LINC), a national leader in specialized technical training, announced today that the New Jersey Board of Nursing has reported 94% of Nursing graduates from its Paramus, NJ campus have passed a key licensing exam on their first attempt.

A surgical team at The Chaim Sheba Medical Center in Tel HaShomer, Israel, with coordination by US Medical Innovations, LLC (USMI), successfully used the Canady HeliosTM Cold Plasma Scalpel (CHCPS) for a rare advanced reoccurring inoperable retroperitoneal sarcoma.

IBH Population Health Solutions (Integrated Behavioral Health, Inc.) announced today that an accomplished healthcare executive has joined the company to help accelerate its nationwide growth.

Jupiter Medical Center is closely monitoring the coronavirus that originated in Wuhan, China, and has implemented the U.S. Centers for Disease Control and Prevention’s guidelines for the screening, diagnosis, and treatment of patients who exhibit the symptoms of and/or are diagnosed with the coronavirus.

Columbia-led study in mice maps brain circuitry that enables a single pheromone to drive both innate and learned sexual behaviors

Synedgen, a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system, today announced that it has received $2.6 million in private financing to fund the commercialization of Catasyn™ Advanced Technology Wound Hydrogel and SynePure™ Wound Cleanser, two U. S. Food and Drug Administration (FDA) 510(k)-cleared products that form part of Synedgen’s Wound Care portfolio.

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2019 financial results on Thursday, February 6, 2020, after the market close.

Today, the U.S. Food and Drug Administration announced the launch of an interactive database that will offer a wealth of critical information about antiretrovirals (ARVs) eligible for purchase under the President’s Emergency Plan for AIDS Relief (PEPFAR) program.

Mark Bennett, MD, NAPA’s Chairman of Anesthesiology at Chestnut Hill Hospital, collaborated with vascular surgeon Douglas A. Troutman, DO, on a successful high-risk surgical procedure at the community hospital located in Philadelphia, PA